A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.
Public ClinicalTrials.gov record NCT02021500. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
MPACT Extension Study: Multicenter, Survival Data Collection in Subjects Previously Enrolled in Protocol CA046
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to collect survival data on patients previously enrolled in Abraxane pancreatic cancer study CA046.
Study identification
- NCT ID
- NCT02021500
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2014 (Actual)
- Primary completion
- Apr 16, 2015 (Actual)
- Completion
- Apr 16, 2015 (Actual)
- Last update posted
- Nov 1, 2019
2014 – 2015
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| TGen Clinical Research Services | Scottsdale | Arizona | 85004 | — |
| Mayo Clinic | Scottsdale | Arizona | 85259-5499 | — |
| Pacific Shores Medical Group | Long Beach | California | 90813 | — |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Florida Cancer Specialists | Englewood | Florida | 34223 | — |
| Florida Cancer Specialist | Tavares | Florida | 32778 | — |
| Indiana University | Indianapolis | Indiana | 46202-5149 | — |
| University of Massachusetts Memorial Medical Center | Worcester | Massachusetts | 01655 | — |
| Arena Oncology Associates | Lake Success | New York | 11042 | — |
| UPMC Cancer Pavillion | Pittsburgh | Pennsylvania | 15232 | — |
| Tennessee Oncology PLLC | Nashville | Tennessee | 37203 | — |
| South Texas Oncology and Hematology (STOH) | San Antonio | Texas | 78229 | — |
| Fairfax-Northern Virginia Haematology-Oncology | Fairfax | Virginia | 22033 | — |
| Virginia Cancer Institute | Richmond | Virginia | 23230 | — |
| Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109 | — |
| Froedtert and Medical College ID Clinic | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02021500, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2019 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02021500 live on ClinicalTrials.gov.